Aims: Neuropeptide substance P (SP) is produced and released by a subset of peripheral sensory neurons that respond to tissue damage (nociceptors). SP exerts excitatory effects in the central nervous system, but peripheral SP actions are still poorly understood; therefore, here, we aimed at investigating these peripheral mechanisms. Results: SP acutely inhibited T-type voltage-gated Ca2+ channels in nociceptors. The effect was mediated by neurokinin 1 (NK1) receptor-induced stimulation of intracellular release of reactive oxygen species (ROS), as it can be prevented or reversed by the reducing agent dithiothreitol and mimicked by exogenous or endogenous ROS. This redox-mediated T-type Ca2+ channel inhibition operated through the modulation of CaV3.2 channel sensitivity to ambient zinc, as it can be prevented or reversed by zinc chelation and mimicked by exogenous zinc. Elimination of the zinc-binding site in CaV3.2 rendered the channel insensitive to SP-mediated inhibition. Importantly, peripherally applied SP significantly reduced bradykinin-induced nociception in rats in vivo; knock-down of CaV3.2 significantly reduced this anti-nociceptive effect. This atypical signaling cascade shared the initial steps with the SP-mediated augmentation of M-type K+ channels described earlier. Innovation: Our study established a mechanism underlying the peripheral anti-nociceptive effect of SP whereby this neuropeptide produces ROS-dependent inhibition of pro-algesic T-type Ca2+ current and concurrent enhancement of anti-algesic M-type K+ current. These findings will lead to a better understanding of mechanisms of endogenous analgesia. Conclusion: SP modulates T-type channel activity in nociceptors by a redox-dependent tuning of channel sensitivity to zinc; this novel modulatory pathway contributes to the peripheral anti-nociceptive effect of SP. Antioxid. Redox Signal. 25, 233–251.
Get full access to this article
View all access options for this article.
References
1.
AbdullaFA, StebbingMJ, and SmithPA. Effects of substance P on excitability and ionic currents of normal and axotomized rat dorsal root ganglion neurons. Eur J Neurosci, 13: 545–552, 2001.
2.
AyoolaC, HwangSM, HongSJ, RoseKE, BoydC, BozicN, ParkJY, OsuruHP, DiGruccioMR, CoveyDF, Jevtovic-TodorovicV, and TodorovicSM. Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone. Psychopharmacology (Berl), 231: 3503–3515, 2014.
3.
BourinetE, AllouiA, MonteilA, BarrereC, CouetteB, PoirotO, PagesA, McRoryJ, SnutchTP, EschalierA, and NargeotJ. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J, 24: 315–324, 2005.
4.
BoycottHE, DallasML, EliesJ, PettingerL, BoyleJP, ScraggJL, GamperN, and PeersC. Carbon monoxide inhibition of Cav3.2 T-type Ca2+ channels reveals tonic modulation by thioredoxin. FASEB J, 27: 3395–3407, 2013.
5.
BrownJL, LiuH, MaggioJE, VignaSR, MantyhPW, and BasbaumAI. Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis. J Comp Neurol, 356: 327–344, 1995.
6.
BusselbergD, MichaelD, EvansML, CarpenterDO, and HaasHL. Zinc (Zn2+) blocks voltage gated calcium channels in cultured rat dorsal root ganglion cells. Brain Res, 593: 77–81, 1992.
7.
CangCL, ZhangH, ZhangYQ, and ZhaoZQ. PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons. Mol Pain, 5: 33, 2009.
8.
CatterallWA, Perez-ReyesE, SnutchTP, and StriessnigJ. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev, 57: 411–425, 2005.
9.
ChenCC, LampingKG, NunoDW, BarresiR, ProutySJ, LavoieJL, CribbsLL, EnglandSK, SigmundCD, WeissRM, WilliamsonRA, HillJA, and CampbellKP. Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels. Science, 302: 1416–1418, 2003.
10.
ChoeW, MessingerRB, LeachE, EckleVS, ObradovicA, SalajeghehR, Jevtovic-TodorovicV, and TodorovicSM. TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent. Mol Pharmacol, 80: 900–910, 2011.
11.
CosteB, CrestM, and DelmasP. Pharmacological dissection and distribution of NaN/Nav1.9, T-type Ca2+ currents, and mechanically activated cation currents in different populations of DRG neurons. J Gen Physiol, 129: 57–77, 2007.
12.
De BiasiS and RustioniA.Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci U S A, 85: 7820–7824, 1988.
13.
DuX, HaoH, GigoutS, HuangD, YangY, LiL, WangC, SundtD, JaffeDB, ZhangH, and GamperN. Control of somatic membrane potential in nociceptive neurons and its implications for peripheral nociceptive transmission. Pain, 155: 2306–2322, 2014.
14.
EliesJ, ScraggJL, BoyleJP, GamperN, and PeersC.Regulation of the T-type Ca channel Cav3.2 by hydrogen sulfide: Emerging controversies concerning the role of H S in nociception. J Physiol, 2016. [Epub ahead of print]; DOI: DOI:10.1113/JP270963.
FlegelC, SchobelN, AltmullerJ, BeckerC, TannapfelA, HattH, and GisselmannG. RNA-Seq analysis of human trigeminal and dorsal root ganglia with a focus on chemoreceptors. PLoS One, 10: e0128951, 2015.
17.
FrancoisA, KerckhoveN, MeleineM, AllouiA, BarrereC, GelotA, UebeleVN, RengerJJ, EschalierA, ArdidD, and BourinetE. State-dependent properties of a new T-type calcium channel blocker enhance CaV3.2 selectivity and support analgesic effects. Pain, 154: 283–293, 2013.
GamperN, ZaikaO, LiY, MartinP, HernandezCC, PerezMR, WangAY, JaffeDB, and ShapiroMS. Oxidative modification of M-type K+ channels as a mechanism of cytoprotective neuronal silencing. EMBO J, 25: 4996–5004, 2006.
20.
Garcia-CaballeroA, GadottiVM, StemkowskiP, WeissN, SouzaIA, HodgkinsonV, BladenC, ChenL, HamidJ, PizzoccaroA, DeageM, FrancoisA, BourinetE, and ZamponiGW. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron, 83: 1144–1158, 2014.
21.
HayashiH, IwataM, TsuchimoriN, and MatsumotoT. Activation of peripheral KCNQ channels attenuates inflammatory pain. Mol Pain, 10: 15, 2014.
22.
HillR.NK1 (substance P) receptor antagonists – Why are they not analgesic in humans?. Trends Pharmacol Sci, 21: 244–246, 2000.
23.
IftincaMC and ZamponiGW. Regulation of neuronal T-type calcium channels. Trends Pharmacol Sci, 30: 32–40, 2009.
24.
Jevtovic-TodorovicV and TodorovicSM. The role of peripheral T-type calcium channels in pain transmission. Cell Calcium, 40: 197–203, 2006.
25.
JinX, ShahS, LiuY, ZhangH, LeesM, FuZ, LippiatJD, BeechDJ, SivaprasadaraoA, BaldwinSA, ZhangH, and GamperN. Activation of the Cl− channel ANO1 by localized calcium signals in nociceptive sensory neurons requires coupling with the IP3 receptor. Sci Signal, 6: ra73, 2013.
26.
KangHW, ParkJY, JeongSW, KimJA, MoonHJ, Perez-ReyesE, and LeeJH. A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels. J Biol Chem, 281: 4823–4830, 2006.
27.
KangHW, VitkoI, LeeSS, Perez-ReyesE, and LeeJH. Structural determinants of the high affinity extracellular zinc binding site on Cav3.2 T-type calcium channels. J Biol Chem, 285: 3271–3281, 2010.
KirtonHM, PettingerL, and GamperN. Transient overexpression of genes in neurons using nucleofection. Methods Mol Biol, 998: 55–64, 2013.
30.
KrezelA, LesniakW, Jezowska-BojczukM, MlynarzP, BrasunJ, KozlowskiH, and BalW. Coordination of heavy metals by dithiothreitol, a commonly used thiol group protectant. J Inorg Biochem, 84: 77–88, 2001.
31.
LeeM.Z944: A first in class T-type calcium channel modulator for the treatment of pain. J Peripher Nerv Syst, 19,Suppl 2: S11–S12, 2014.
32.
LinCC, ChenWN, ChenCJ, LinYW, ZimmerA, and ChenCC. An antinociceptive role for substance P in acid-induced chronic muscle pain. Proc Natl Acad Sci U S A, 109: E76–E83, 2012.
33.
LinleyJE, OoiL, PettingerL, KirtonH, BoyleJP, PeersC, and GamperN. Reactive oxygen species are second messengers of neurokinin signaling in peripheral sensory neurons. Proc Natl Acad Sci U S A, 109: E1578–E1586, 2012.
34.
LinleyJE, PettingerL, HuangD, and GamperN. M channel enhancers and physiological M channel block. J Physiol, 590: 793–807, 2012.
35.
LinleyJE, RoseK, PatilM, RobertsonB, AkopianAN, and GamperN. Inhibition of M current in sensory neurons by exogenous proteases: A signaling pathway mediating inflammatory nociception. J Neurosci, 28: 11240–11249, 2008.
36.
LiuB, LinleyJE, DuX, ZhangX, OoiL, ZhangH, and GamperN. The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl- channels. J Clin Invest, 120: 1240–1252, 2010.
37.
MacdonaldSG, DumasJJ, and BoydND. Chemical cross-linking of the substance P (NK-1) receptor to the alpha subunits of the G proteins Gq and G11. Biochemistry, 35: 2909–2916, 1996.
38.
MalcangioM and BoweryNG. Peptide autoreceptors: Does an autoreceptor for substance P exist?. Trends Pharmacol Sci, 20: 405–407, 1999.
39.
ManteniotisS, LehmannR, FlegelC, VogelF, HofreuterA, SchreinerBS, AltmullerJ, BeckerC, SchobelN, HattH, and GisselmannG. Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia. PLoS One, 8: e79523, 2013.
40.
McMahonSB, BennetDLH, and BevanS. Inflammatory mediators and modulators. In: Wall and Melzack's Textbook of Pain, edited by McMahonSB and KoltzenburgM.Edinburgh: Elsevier Churchill Livingstone, 2006, pp. 49–72.
41.
MessingerRB, NaikAK, JagodicMM, NelsonMT, LeeWY, ChoeWJ, OrestesP, LathamJR, TodorovicSM, and Jevtovic-TodorovicV. In vivo silencing of the CaV3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain, 145: 184–195, 2009.
42.
MestreC, PelissierT, FialipJ, WilcoxG, and EschalierA. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods, 32: 197–200, 1994.
43.
MezaU, ThapliyalA, BannisterRA, and AdamsBA. Neurokinin 1 receptors trigger overlapping stimulation and inhibition of CaV2.3 (R-type) calcium channels. Mol Pharmacol, 71: 284–293, 2007.
44.
MoranVH, StammersAL, MedinaMW, PatelS, DykesF, SouvereinOW, DullemeijerC, Perez-RodrigoC, Serra-MajemL, NissensohnM, and LoweNM. The relationship between zinc intake and serum/plasma zinc concentration in children: A systematic review and dose-response meta-analysis. Nutrients, 4: 841–858, 2012.
45.
MoriguchiS, ShiodaN, YamamotoY, TagashiraH, and FukunagaK. The T-type voltage-gated calcium channel as a molecular target of the novel cognitive enhancer ST101: Enhancement of long-term potentiation and CaMKII autophosphorylation in rat cortical slices. J Neurochem, 121: 44–53, 2012.
46.
NelsonMT, JoksovicPM, Perez-ReyesE, and TodorovicSM. The endogenous redox agent L-cysteine induces T-type Ca2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. J Neurosci, 25: 8766–8775, 2005.
47.
NelsonMT, JoksovicPM, SuP, KangHW, Van DeusenA, BaumgartJP, DavidLS, SnutchTP, BarrettPQ, LeeJH, ZorumskiCF, Perez-ReyesE, and TodorovicSM. Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J Neurosci, 27: 12577–12583, 2007.
48.
NelsonMT, WooJ, KangHW, VitkoI, BarrettPQ, Perez-ReyesE, LeeJH, ShinHS, and TodorovicSM. Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. J Neurosci, 27: 8250–8260, 2007.
49.
OrestesP, BojadzicD, LeeJ, LeachE, SalajeghehR, DigruccioMR, NelsonMT, and TodorovicSM. Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway. J Physiol, 589: 135–148, 2011.
50.
PassmoreGM, ReillyJM, ThakurM, KeasberryVN, MarshSJ, DickensonAH, and BrownDA. Functional significance of M-type potassium channels in nociceptive cutaneous sensory endings. Front Mol Neurosci, 5: 63, 2012.
PethoG and ReehPW. Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors. Physiol Rev, 92: 1699–1775, 2012.
53.
RanadeSS, WooSH, DubinAE, MoshourabRA, WetzelC, PetrusM, MathurJ, BegayV, CosteB, MainquistJ, WilsonAJ, FranciscoAG, ReddyK, QiuZ, WoodJN, LewinGR, and PatapoutianA. Piezo2 is the major transducer of mechanical forces for touch sensation in mice. Nature, 516: 121–125, 2014.
54.
RichardsonJD and VaskoMR. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther, 302: 839–845, 2002.
55.
RolaR, SzulczykPJ, and WitkowskiG. Voltage-dependent Ca2+ currents in rat cardiac dorsal root ganglion neurons. Brain Res, 961: 171–178, 2003.
56.
RoseKE, LunardiN, BoscoloA, DongX, ErisirA, Jevtovic-TodorovicV, and TodorovicSM. Immunohistological demonstration of CaV3.2 T-type voltage-gated calcium channel expression in soma of dorsal root ganglion neurons and peripheral axons of rat and mouse. Neuroscience, 250: 263–274, 2013.
57.
SculptoreanuA, Aura KullmannF, and de GroatWC. Neurokinin 2 receptor-mediated activation of protein kinase C modulates capsaicin responses in DRG neurons from adult rats. Eur J Neurosci, 27: 3171–3181, 2008.
58.
SculptoreanuA, and de GroatWC. Protein kinase C is involved in neurokinin receptor modulation of N- and L-type Ca2+ channels in DRG neurons of the adult rat. J Neurophysiol, 90: 21–31, 2003.
59.
SindrupSH, GrafA, and SfikasN. The NK1-receptor antagonist TKA731 in painful diabetic neuropathy: A randomised, controlled trial. Eur J Pain, 10: 567–571, 2006.
60.
SpringerJ, GronebergDA, DinhQT, QuarcooD, HamelmannE, Braun-DullaeusRC, GeppettiP, AnkerSD, and FischerA. Neurokinin-1 receptor activation induces reactive oxygen species and epithelial damage in allergic airway inflammation. Clin Exp Allergy, 37: 1788–1797, 2007.
61.
StadtmanER.Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci, 928: 22–38, 2001.
62.
SteinhoffMS, von MentzerB, GeppettiP, PothoulakisC, and BunnettNW. Tachykinins and their receptors: Contributions to physiological control and the mechanisms of disease. Physiol Rev, 94: 265–301, 2014.
63.
TalleyEM, CribbsLL, LeeJH, DaudA, Perez-ReyesE, and BaylissDA. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci, 19: 1895–1911, 1999.
64.
TanabeT, OtaniH, BaoL, MikamiY, YasukuraT, NinomiyaT, OgawaR, and InagakiC. Intracellular signaling pathway of substance P-induced superoxide production in human neutrophils. Eur J Pharmacol, 299: 187–195, 1996.
65.
TodorovicSM, Jevtovic-TodorovicV, MeyenburgA, MennerickS, Perez-ReyesE, RomanoC, OlneyJW, and ZorumskiCF. Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron, 31: 75–85, 2001.
66.
TraboulsieA, CheminJ, ChevalierM, QuignardJF, NargeotJ, and LoryP. Subunit-specific modulation of T-type calcium channels by zinc. J Physiol, 578: 159–171, 2007.
UsoskinD, FurlanA, IslamS, AbdoH, LonnerbergP, LouD, Hjerling-LefflerJ, HaeggstromJ, KharchenkoO, KharchenkoPV, LinnarssonS, and ErnforsP. Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing. Nat Neurosci, 18: 145–153, 2015.
69.
von Bohlen und HalbachO and DermietzelR.Neurotransmitters and Neuromediators. Handbook of Receptors and Biological Effects. Weinheim: Wiley-Vch Verlag Gmbh & Co., 2006, p. 386.
70.
WangW, FangH, GroomL, ChengA, ZhangW, LiuJ, WangX, LiK, HanP, ZhengM, YinJ, WangW, MattsonMP, KaoJP, LakattaEG, SheuSS, OuyangK, ChenJ, DirksenRT, and ChengH. Superoxide flashes in single mitochondria. Cell, 134: 279–290, 2008.
71.
WaxmanSG and ZamponiGW. Regulating excitability of peripheral afferents: Emerging ion channel targets. Nat Neurosci, 17: 153–163, 2014.
72.
WeidnerC, KledeM, RukwiedR, LischetzkiG, NeisiusU, SkovPS, PetersenLJ, and SchmelzM. Acute effects of substance P and calcitonin gene-related peptide in human skin – A microdialysis study. J Invest Dermatol, 115: 1015–1020, 2000.
73.
ZhangH, CangCL, KawasakiY, LiangLL, ZhangYQ, JiRR, and ZhaoZQ. Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: A novel pathway for heat hyperalgesia. J Neurosci, 27: 12067–12077, 2007.
74.
ZhangX, PietraC, LovatiE, and de GroatWC. Activation of neurokinin-1 receptors increases the excitability of guinea pig dorsal root ganglion cells. J Pharmacol Exp Ther, 343: 44–52, 2012.
75.
ZhangY, QinW, QianZ, LiuX, WangH, GongS, SunYG, SnutchTP, JiangX, and TaoJ. Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels. Sci Signal, 7: ra94, 2014.
76.
ZorovDB, FilburnCR, KlotzLO, ZweierJL, and SollottSJ. Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med, 192: 1001–1014, 2000.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
